Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Hannelore I Bax"'
Autor:
Saskia E. Mudde, Jodie A. Schildkraut, Nicole C. Ammerman, Corné P. de Vogel, Jurriaan E.M. de Steenwinkel, Jakko van Ingen, Hannelore I. Bax
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 31, Iss , Pp 345-352 (2022)
ABSTRACT: Objectives: Mycobacterium abscessus is an opportunistic respiratory pathogen in patients with underlying lung disease. It is infamously known for its low treatment success rates because of its resistance to multiple classes of antibiotics.
Externí odkaz:
https://doaj.org/article/64f40b3ee8c649f5b13b24f9e90cc139
Autor:
Elske Sieswerda, Hannelore I. Bax, Jacobien J. Hoogerwerf, Mark G. J. de Boer, Marja Boermeester, Marc J. M. Bonten, Douwe Dekker, Roy Gerth van Wijk, Nicole P. Juffermans, Marnix Kuindersma, Paul D. van der Linden, Damian C. Melles, Peter Pickkers, Jeroen A. Schouten, Jasper R. Rebel, Arthur R. H. van Zanten, Jan M. Prins, W. Joost Wiersinga
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background The Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on empiric antibacterial therapy of sepsis in adults. Methods Our multidiscipli
Externí odkaz:
https://doaj.org/article/428bc82ef7f045c2b74f25abb5e6bb8a
Autor:
Nelianne J. Verkaik, Yunus C. Yalcin, Hannelore I. Bax, Alina A. Constantinescu, Jasper J. Brugts, Olivier C. Manintveld, Ozcan Birim, Peter D. Croughs, Ad J. J. C. Bogers, Kadir Caliskan
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
PurposeBecause of the current lack of evidence-based antimicrobial treatment guidelines, Left Ventricular Assist Device (LVAD) infections are often treated according to local insights. Here, we propose a flowchart for protocolized treatment, in order
Externí odkaz:
https://doaj.org/article/5208c804656949178ea5db366c227c13
Autor:
S Reshwan K Malahe, Rogier A S Hoek, Virgil A S H Dalm, Annoek E C Broers, Caroline M den Hoed, Olivier C Manintveld, Carla C Baan, Charlotte M van Deuzen, Grigorios Papageorgiou, Hannelore I Bax, Jeroen J Van Kampen, Merel E Hellemons, Marcia M L Kho, Rory D de Vries, Richard Molenkamp, Marlies E J Reinders, Bart J A Rijnders
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(3):ciac571, e172-e178. Oxford University Press
Background Illness after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is less severe compared with previous variants. Data on the disease burden in immunocompromised patients are lacking. We investig
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 8, p 1743 (2021)
Infective endocarditis, osteomyelitis, and osteosynthesis-associated infections are mostly caused by Gram-positive bacteria. They are often difficult to treat and are associated with a poor prognosis. In the past 20 years, nine antibiotic drugs with
Externí odkaz:
https://doaj.org/article/8638ba23607743ddb4eb6c00f8fd2bd1
Autor:
Saskia E. Mudde, Anna M. Upton, Anne Lenaerts, Hannelore I. Bax, Jurriaan E. M. De Steenwinkel
Publikováno v:
The Journal of antimicrobial chemotherapy, 77(4), 880-902. Oxford University Press
Given the low treatment success rates of drug-resistant tuberculosis (TB), novel TB drugs are urgently needed. The landscape of TB treatment has changed considerably over the last decade with the approval of three new compounds: bedaquiline, delamani
Autor:
Henrieke A. B. Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J. Overmars, Grigorius Papageorgiou, Yvonne M. Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J. A. Rijnders, Hannelore I. Bax, Eric C. M. van Gorp, Jan L. Nouwen, Theodora E. M. S. de Vries-Sluijs, Carolina A. M. Schurink, Mariana de Mendonça Melo, Els van Nood, Angela Colbers, David Burger, Robert-Jan Palstra, Jeroen J. A. van Kampen, David A. M. C. van de Vijver, Thibault Mesplède, Peter D. Katsikis, Rob A. Gruters, Birgit C. P. Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx
Publikováno v:
Science Advances, 9
Science Advances, 9, 11
Science advances, 9(11):eade6675. American Association for the Advancement of Science
Science Advances, 9, 11
Science advances, 9(11):eade6675. American Association for the Advancement of Science
Contains fulltext : 291084.pdf (Publisher’s version ) (Open Access) Reactivation of the latent HIV-1 reservoir is a first step toward triggering reservoir decay. Here, we investigated the impact of the BAF complex inhibitor pyrimethamine on the res
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5, p 1068 (2021)
Infections in the ICU are often caused by Gram-negative bacteria. When these microorganisms are resistant to third-generation cephalosporines (due to extended-spectrum (ESBL) or AmpC beta-lactamases) or to carbapenems (for example carbapenem producin
Externí odkaz:
https://doaj.org/article/1ba4a99a276e4cf3a0a1570b880cd4a5
Autor:
Jurriaan E. M. de Steenwinkel, Rami Ayoun Alsoud, Hannelore I. Bax, Saskia E. Mudde, Manisha U. Lotlikar, Aart van der Meijden, Anna M. Upton, Ulrika S. H. Simonsson
Publikováno v:
The Journal of infectious diseases, 225(11), 1876-1885. Oxford University Press
Background Given the persistently high global burden of tuberculosis, effective and shorter treatment options are needed. We explored the relationship between relapse and treatment length as well as interregimen differences for 2 novel antituberculos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83548a6b4c01dd3d15020141c91896b1
https://pure.eur.nl/en/publications/df56d81f-b9de-48b0-8768-1143a3afc237
https://pure.eur.nl/en/publications/df56d81f-b9de-48b0-8768-1143a3afc237
Autor:
S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A.S.H. Dalm, Annoek E.C. Broers, Caroline M. den Hoed, Olivier C. Manintveld, Carla C. Baan, Charlotte M. van Deuzen, Grigorios Papageorgiou, Hannelore I. Bax, Jeroen J. Van Kampen, Merel E. Hellemons, Marcia M.L. Kho, Rory D. de Vries, Richard Molenkamp, Marlies E.J. Reinders, Bart J.A. Rijnders
BackgroundIn the general population, illness after infection with the SARS-CoV-2 Omicron variant is less severe compared with previous variants. Data on the disease burden of Omicron in immunocompromised patients are lacking. We investigated the clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9061f97ec953075968ede86cbbb2d29
https://doi.org/10.1101/2022.04.25.22273197
https://doi.org/10.1101/2022.04.25.22273197